Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system

被引：70
|
作者：
Wildemeersch, D [1 ]
Dhont, M
机构：
[1] Univ Hosp, Gynecol Res Unit, Knokke, Belgium
[2] State Univ Ghent Hosp, Dept Obstet & Gynecol, B-9000 Ghent, Belgium
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2003年 / 188卷 / 05期
关键词：
frameless in trauterine system; levonorgestrel; endometrial hyperplasia;
D O I：
10.1067/mob.2003.346
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
OBJECTIVE: A "frameless" intrauterine drug delivery system that releases 14 mug/d of levonorgestrel was used to treat nonatypical and atypical endometrial hyperplasia in 12 women. STUDY DESIGN: This noncomparative study had up to 3 to 4 years of follow-up. RESULTS: The cure rate was 100%, as confirmed by repeat endometrial biopsy. CONCLUSION: This method could be considered an alternative to hysterectomy.
引用
收藏
页码：1297 / 1298
页数：2
相关论文
共 50 条
  • [1] Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia
    Luo, Li
    Luo, Bing
    Zheng, Ying
    Zhang, Heng
    Li, Jing
    Sidell, Neil
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
  • [2] Levonorgestrel-Releasing Intrauterine System for Endometrial Hyperplasia
    Mittermeier, Theresa
    Farrant, Charlotte
    Wise, Michelle R.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (10) : 601 - 602
  • [3] ORAL PROGESTINS VS LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM IN TREATMENT OF ATYPICAL ENDOMETRIAL HYPERPLASIA
    Lee, Shi Hui
    Ling, Pearl Wee
    Goh, Charissa
    Chin, Felicia
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A186 - A186
  • [4] Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system
    Kresowik, J.
    Ryan, G. L.
    Van Voorhis, B. J.
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (02): : 547 - 549
  • [5] Levonorgestrel-releasing intrauterine system for endometrial hyperplasia (Review)
    Mittermeier, T.
    Farrant, C.
    Wise, M. R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (09):
  • [6] Use of Levonorgestrel-Releasing Intrauterine System in the Prevention and Treatment of Endometrial Hyperplasia
    Ewies, Ayman A. A.
    Alfhaily, Fadi
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2012, 67 (11) : 726 - 733
  • [7] Safety and efficacy of levonorgestrel-releasing intrauterine device in the treatment of atypical endometrial hyperplasia and early endometrial cancer
    Hirata, Toru
    Kondo, Eiji
    Magawa, Shoichi
    Kubo-Kaneda, Michiko
    Nii, Masafumi
    Yoshida, Kenta
    Maezawa, Tadashi
    Tabata, Tsutomu
    Ikeda, Tomoaki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (12) : 3219 - 3225
  • [8] Levonorgestrel-releasing intrauterine system (Mirena®) as a therapy for endometrial hyperplasia and carcinoma
    Bahamondes, L
    Ribeiro-Huguet, P
    de Andrade, KC
    Leon-Martins, O
    Petta, CA
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (06) : 580 - 582
  • [9] Levonorgestrel-Releasing Intrauterine System vs. Oral Progestins for Treatment of Endometrial Hyperplasia
    Liegl, Sarah
    AMERICAN FAMILY PHYSICIAN, 2016, 93 (11) : 948 - 949
  • [10] Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device
    Penick, Emily
    OBSTETRICS AND GYNECOLOGY, 2018, 131 (04): : 737 - 738
12345